V ascular dementia is the second most common cause of dementia 1 and is increasing in prevalence in developing countries. 2 Vascular dementia usually occurs in association with vascular risk factors or after transient ischemic attack (TIA) or stroke 3 and commonly manifests with a decline in cognitive function, apathy, and depression, and can eventually result in death. 1, 4 Blood pressure (BP), a known causal risk factor for stroke, 5 has also been identified as a potential risk factor for vascular dementia. 6 However, studies have reported conflicting results on the relation between BP and vascular dementia ( Table I in the online-only Data Supplement). 6 Previous analyses of healthy cohorts and patients with previous diagnosis of TIA or stroke have suggested a positive association between midlife BP (age 40-50 years) and future development of dementia, including vascular dementia. 7-9 However, several other studies have suggested that low BP in old age is associated with an increased risk of dementia ( Table I in the online-only Data Supplement). 10,11 The reported negative associations between BP and risk of vascular dementia at older ages may be caused by reverse causality, that is, vascular dementia causing low BP, because of loss of sympathetic drive, rather than low BP causing vascular dementia. 12 Null or negative associations could also result from the prior prescription of BP-lowering drugs. Previous studies have been relatively small, limiting their ability to Background and Purpose-Vascular dementia is the second most common form of dementia but reliable evidence on agespecific associations between blood pressure (BP) and risk of vascular dementia is limited and some studies have reported negative associations at older ages. Methods-In a cohort of 4.28 million individuals, free of known vascular disease and dementia and identified from linked electronic primary care health records in the United Kingdom (Clinical Practice Research Datalink), we related BP to time to physician-diagnosed vascular dementia. We further determined associations between BP and dementia in a prospective population-based cohort of incident transient ischemic attack and stroke (Oxford Vascular Study). Results-For a median follow-up of 7.0 years, 11 114 initial presentations of vascular dementia were observed in the primary care cohort after exclusion of the first 4 years of follow-up. The association between usual systolic BP and risk of vascular dementia decreased with age (hazard ratio per 20 mm Hg higher systolic BP, 1.62; 95% confidence interval, 1.13-2.35 at 30-50 years; 1.26, 1.18-1.35 at 51-70 years; 0.97, 0.92-1.03 at 71-90 years; P trend=0.006). Usual systolic BP remained predictive of vascular dementia after accounting for effect mediation by stroke and transient ischemic attack.
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To clarify these uncertainties, we sought to determine the associations between BP and risk of vascular dementia both in individuals without prior TIA or stroke and in individuals after TIA and stroke. We therefore undertook an analysis of 4.28 million individuals free from vascular disease and dementia in a contemporary United Kingdom primary care population, supplemented with an analysis of a prospective population-based cohort of patients with TIA and stroke in the Oxfordshire region.
Methods

Data Sources, Population, and Exposure
We used linked electronic health records which have been validated for epidemiological research 13 and previously used to examine the relation between BP and vascular events. 14, 15 We used data from the Clinical Practice Research Datalink (primary care records), linked to Hospital Episode Statistics (hospitalization records) and Office of National Statistics Mortality data (cause-specific mortality records). All baseline and exposure covariates were defined through the primary care database. Outcomes (ie, diagnoses of vascular dementia) were defined as the first event from any of the linked data sources, as previously performed. 16 Patients were eligible for inclusion if they were between the ages of 30 and 90 years, inclusive, and had a BP measurement performed between January 1, 1990 and January 1, 2013 at their general practice. We excluded individuals aged >90 years at baseline who were viewed as being more likely to have undiagnosed vascular dementia causing lower BP (ie, more likely to cause reverse causality). Patients additionally had to have their age recorded and registered at a research-standard general practice for at least 1 year. Baseline covariates, including body mass index (BMI), smoking status, total cholesterol, HDL cholesterol, diabetes mellitus were defined using existing phenotyping algorithms. 17 The baseline value for each covariate was defined as the closest measurement within 2 years of the baseline BP measurement of the covariate. To minimize the risk of reverse causality and confounding (eg, preexisting cardiovascular disease causing a reduced BP, while predisposing individuals to an increased risk of vascular dementia), we excluded all individuals with preexisting cardiovascular disease. This was defined as any diagnosis (either during hospitalization or in primary care) before the baseline BP measurement of ischemic heart disease (including angina and myocardial infarction), cerebrovascular disease, peripheral arterial disease, heart failure, atrial fibrillation, or chronic kidney disease.
End Points
We used an inclusive definition of vascular dementia (International Classification of Diseases 10 code: F01, Read codes provided in Table II in the online-only Data Supplement), defining it as any form of dementia with a physician-diagnosed vascular component. Therefore, for our primary analysis, we considered vascular dementia to be all cases of vascular dementia regardless of the coexistence of Alzheimer disease (ie, mixed dementia). As a secondary analysis, we excluded all individuals diagnosed with Alzheimer disease as well as individuals prescribed with donepezil, galantamine, memantine, and rivastigmine, which are largely used to treat Alzheimer disease. 18 For all analyses, participants were censored at the earliest of an occurrence of the primary outcome, transfer out of practice, death, or last collection date of practice. To minimize the risk of reverse causality, 19 that is, undiagnosed dementia causing low BP, the first 4 years of follow-up were excluded in the primary analysis.
Statistical Analysis
Cox models, stratified by practice, were used to determine hazard ratios (HR) for the association between BP and risk of vascular dementia, while accounting for clustering of patients by practice. BP was analyzed both as a categorical variable, which does not assume any particular shape of the association between BP and vascular risk, and as a continuous variable, which assumes a linear relationship. The primary analysis was adjusted for age, sex, BMI, and smoking status. Proportional hazards assumption was tested by plotting Schoenfeld residuals. Multiple imputation using chained equations was used to impute missing covariates (BMI and smoking for the primary analysis, total cholesterol and HDL cholesterol for the secondary analysis); five imputations were generated. Regression dilution bias was adjusted for using serial measurements of BP (Methods in the online-only Data Supplement).
Sensitivity Analyses
Five sensitivity analyses were conducted. First, models were further adjusted for total cholesterol, HDL cholesterol, and the presence of diabetes mellitus. Second, models were further adjusted for socioeconomic status and for year of the initial BP measurement, as a categorical variable (1990-1994, 1995-1999, 2000-2004, 2005-2009, and 2010-2013) . Third, individuals prescribed with antihypertensive medication or lipid-lowering drugs at baseline or during follow-up were excluded. Fourth, individuals with mixed dementia (ie, diagnosed with both Alzheimer disease and vascular dementia) and individuals diagnosed with vascular dementia, but also prescribed with donepezil, galantamine, memantine, and rivastigmine were excluded. Fifth, events within the first 0 to 2, 2 to 4, 4 to 6, 6 to 8, and >8 years of follow-up for individuals aged 71 to 90 years were examined to determine whether previously described inverse associations between BP and risk of dementia in old age were caused by reverse causality. 6 To investigate to what extent the potential association between BP and vascular dementia was mediated by stroke or TIA, we adjusted for occurrence of stroke or TIA during follow-up (Methods in the online-only Data Supplement).
Oxford Vascular Study Cohort
To confirm findings independently, we studied the association between prior BP and subsequent risk of dementia in a populationbased cohort of all individuals with a first TIA or stroke (Oxford Vascular Study; OXVASC) recruited from April 1, 2002 to March 31, 2012 . The methods of ascertainment and follow-up in OXVASC have been reported previously, 20 and are summarized in the Appendix in the online-only Data Supplement. This cohort has 2 advantages in relation to the described primary care cohort. First, all patients underwent cognitive screening after their initial TIA or stroke to exclude premorbid or baseline dementia and the subsequent diagnosis of dementia was made by a dementia specialist physician, based mainly on prospective face-to-face follow-up in clinic or at home using a multidomain screening tool (Methods in the online-only Data Supplement). These assessments were made without knowledge of the data on prior BP, which were collected by independent investigators from the primary care records, thereby reducing the potential risk of biased outcome reporting and classification because of differences in BP. Second, because the predominant type of dementia in this cohort is vascular, we were able to study the risk of all dementia on followup, thereby eliminating any potential diagnostic bias whereby cases of dementia were more likely to be diagnosed as vascular dementia because of a history of hypertension or in light of recent BP readings. The 5-year risk of new dementia during follow-up in OXVASC was related to mean premorbid BP on the basis of all readings recorded in primary care records since 1990 using a Cox model with and without adjustment for age, sex, smoking, and BMI.
Results
In the primary care cohort, 4.7 million individuals had at least 1 acceptable BP measurement at baseline and were eligible for inclusion in the analysis ( Figure I Table III in the online-only Data Supplement.
In total, 14 934 patients were reported to have vascular dementia during follow-up. Three thousand eight hundred and twenty of these presentations were recorded in the first 4 years of follow-up and excluded from the primary analysis. Therefore, 11 114 cases of vascular dementia were included in the primary analysis.
The association between usual systolic BP (SBP) and risk of vascular dementia seemed broadly linear within the age groups of 30 to 50 and 51 to 70 years ( Figure 1 ). No clear evidence of a nadir was observed, although floating risks seemed to plateau at ≈120 mm Hg SBP in both the 30 to 50-year and 51 to 70-year age groups. In contrast, in the age group of 71 to 90 years, floating risks of vascular dementia showed no significant association with baseline SBP. The strength of association per 20 mm Hg higher usual SBP diminished with increasing age category, from an HR of 1.62 (95% confidence interval [CI], 1.13-2.35) in the age group 30 to 50 years to an HR of 1.26 (95% CI, 1.18-1.35) in the age group of 51 to 70 years and to an HR of 0.97 (95% CI, 0.92-1.03) in the age group 71 to 90 years (P trend=0.006; Figures 1 and 2 ). There was no evidence of interaction by sex ( Figure 1 ). Estimates for usual baseline diastolic BP (DBP) were similar (Figures 1 and 2) to usual SBP.
Estimates per 20 mm Hg higher SBP were similar when models were further adjusted for total cholesterol, HDL cholesterol and baseline diabetes mellitus ( Figure II When individuals prescribed with antihypertensive and lipid-lowering therapies at baseline or during follow-up were excluded, the HR per 20 mm Hg higher SBP was strengthened in the age group 51 to 70 years (HR, 1.56; CI, 1.31-1.85), although there were too few events to reliably ascertain the association in the age group 31 to 50 years ( Figure IV in the online-only Data Supplement). Estimates were similar when individuals diagnosed with Alzheimer disease or prescribed with anti-dementia drugs (in addition to a diagnosis of vascular dementia) were excluded ( Figure V in the online-only Data Supplement). Overall, for individuals aged ≤70 years at baseline, 20 mm Hg higher usual SBP was associated with a 26% higher risk of vascular dementia (HR, 1.26; CI, 1.17-1.34; Figure 3 ).
When only events in the first 2 years were considered, significant negative associations with both SBP (HR, 0.51; CI, 0.45-0.56 per 20 mm Hg higher usual SBP) and DBP (HR, 0.61; CI, 0.54-0.70 per 10 mm Hg higher usual DBP) were observed for the age group 71 to 90 years ( Figure 4 ). However, progressive examination of greater lengths of follow-up reduced the measured negative association for both SBP and DBP. Indeed, after exclusion of the first 8 years of followup, no significant association with SBP or DBP was observed. Tests for interaction by period of follow-up were highly significant (P heterogeneity <0.0001).
In the primary care cohort, a total of 27 316 TIA events and 38 199 stroke events were observed after exclusion of the first 4 years of follow-up. Adjustment for both TIA and stroke reduced the HR to 1.18 (CI, 1.10-1.26), indicating that 30% of excess risk of vascular dementia per 20 mm Hg higher SBP is mediated through future stroke and TIA ( Figure VI 
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In the OXVASC cohort, 1680 patients with a recent first TIA or stroke did not have dementia at baseline assessment. Mean (interquartile range) age was 74 (64-82) years, 823 (49.2%) were women, 232 (13.8%) were diabetic, 739 (44.0%) had never smoked, and 985 (58.6%) were on prior BP-lowering medication. During 5-year follow-up, 314 patients developed new dementia. Risk of new dementia was unrelated to the most recent premorbid SBP or DBP in patients (Table) . However, there were significant positive associations with both DBP and SBP in 5 to 9 years before TIA/stroke and particularly before 10 to 20 years (Table) . These associations were stronger in patients aged <75 years Hazard ratio per 20 mm Hg higher than usual systolic blood pressure and 10 mm Hg higher than usual diastolic blood pressure in the primary care cohort. Model adjusted for BMI, smoking status, sex, age category, an interaction term between age category and continuous age, and an interaction term between age category and blood pressure (plotted). No. VaD refers to the number of vascular dementia events. CI indicates confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; and SBP, systolic blood pressure.
Figure 3.
Risk of vascular dementia by onset of dementia (early onset: age at diagnosis or end of follow-up <65 years, late onset: age at diagnosis or end of follow-up ≥65 years), body mass index (BMI), and sex for individuals ≤70 years at baseline in the primary care cohort. Models adjusted for age, BMI, sex, and smoking status. Models in subgroups further adjusted for an interaction term between blood pressure (BP) and age at event (plotted, Onset subgroup), BMI categories, and an interaction term between BP and BMI categories (plotted, BMI subgroup), an interaction term between BP and sex (plotted, sex subgroup). No. VaD refers to the number of vascular dementia events. CI indicates confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; and SBP, systolic blood pressure. 
Discussion
In our main analysis of 4.28 million individuals and 11 114 presentations of vascular dementia, BP was found to be continuously associated with future risk of vascular dementia, with a possible plateau at 120 mm Hg. The association between BP and risk of vascular dementia declined with increasing age, from a 62% higher risk per 20 mm Hg higher SBP in the age group 30 to 50 years to a nonsignificant association in the age group of 71 to 90 years when early events after start of follow-up were excluded. A large proportion of the association between BP and risk of vascular dementia in the age group 30 to 70 years was mediated by future stroke and TIA.
Findings were broadly similar in our analysis of the risk of new dementia in the OXVASC patients with TIA or stroke. Indeed, a major strength of our study is the combination of the big data from the Clinical Practice Research Datalink with the more deeply phenotyped prospective population-based data from OXVASC. Risk of dementia within 5 years of recruitment into OXVASC was unrelated to the most recent premorbid BP, but no statistically significant negative associations were observed even in this group. Significant positive associations with both DBP and SBP were observed with measurements 5 to 9 years and 10 to 20 years before TIA or stroke.
Previous studies ( Table I in the online-only Data Supplement) have been limited by relatively small sample sizes and have provided conflicting results on the relation between BP and vascular dementia. In an analysis of the relation between midlife BP and vascular dementia, with 38 presentations of vascular dementia, SBP was significantly and positively related to the risk of vascular dementia (odds ratio, 1.33; CI, 1.14-1.56 per 10 mm Hg higher SBP). 9 In contrast, in an analysis of 6668 participants aged ≥55 years with 46 presentations of vascular dementia, no significant association between SBP and risk of vascular dementia was observed. 10 An inverse association was observed in a cross-sectional analysis of 1642 individuals, with hypertensive individuals (SBP≥140 mm Hg) having a 50% lower odds (odds ratio, 0.5; CI, 0.27-0.92) of developing vascular dementia than nonhypertensive individuals. 11 In relation to mean premorbid blood pressure (HR per 20/10 mm Hg increase in mean SBP/DBP) readings in cohort of patients with a first TIA) or stroke (Oxford Vascular Study cohort) stratified by measurement period (years before TIA/stroke), with 2 sensitivity analyses: (1) excluding patients on BP-lowering medication before the first TIA/stroke; (2) excluding dementia with onset after recurrent stroke. BP indicates blood pressure; CI, confidence interval; DBP, diastolic blood pressure; HR, hazard ratio; SBP, systolic blood pressure; and TIA, transient ischemic attack. 
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Our results characterize the age-dependent relation between BP and risk of vascular dementia and support the previously reported positive associations between BP in midlife and vascular dementia. Our estimate of an HR of 1.62 (CI, 1.13-2.35) in the age group 30 to 50 years in the primary care cohort is consistent with that of Yamada et al, 9 who estimated an odds ratio of 1.77 (CI, 1.30-2.43) per 20 mm Hg higher SBP in a population where the large majority of participants were in the age of 30 to 50 years at baseline. However, contrary to previous analyses suggesting that late-life BP has either no association or an inverse association with risk of vascular dementia, our results demonstrate that elevated BP in the age range of 51 to 70 years is a significant risk factor for vascular dementia and refutes earlier reports of an inverse association between BP and risk of vascular dementia in the age range of 71 to 90 years. Although we observed a negative association between SBP and DBP and risk of vascular dementia within the first 2 years of follow-up, consistent with previous analyses, 11 this association disappeared after excluding the first 4 years of follow-up. Similarly, in the OXVASC cohort of patients with symptomatic cerebrovascular disease, there was no suggestion of a negative association even at age >75 years. These results suggest that previously reported inverse associations between BP and risk of vascular dementia are caused by reverse causality, and are not because of reduced cerebral perfusion causing vascular dementia, as has been previously suggested. 6, 12, 21 Recent studies have suggested that elevated BP may be unassociated with incident Alzheimer disease, 22 and or may be inversely associated. 23 These findings, which differ from the current analysis, may be because of methodological differences or may reflect genuine differences in the pathophysiology of vascular dementia relative to Alzheimer disease. In favor of the former hypothesis is evidence of a shared pathology between Alzheimer disease and vascular dementia, which suggests that classification of either disease is not rigid. 24 Furthermore, vascular dementia may represent a heterogeneous group of disorders with differing pathophysiologies and courses depending on the source of dementia (eg, large infarction versus small vessel disease). 25 Advances in classification and clinical diagnosis of subtypes of dementia may allow for more consistent estimation of associations with risk factors in epidemiological studies.
Assuming causality, our results suggest that individual or population-based methods to lower BP, even late in life, may further reduce the incidence of vascular dementia. Because our results also indicate that a large proportion of the association of BP with risk of vascular dementia is mediated through stroke and TIA, efforts to prevent these forms of cerebrovascular disease, as well as efforts to rapidly treat stroke and TIA, may further reduce the future burden of vascular dementia in developed and developing countries. However, when considering that only 30% of the excess risk of vascular dementia associated with a 20 mm Hg higher SBP was mediated by future stroke or TIA in the Clinical Practice Research Datalink analysis, efforts to reduce BP are likely to have a larger impact in reducing the risk of vascular dementia than that expected simply from prevention and treatment of overt stroke or TIA.
Our analysis of the primary care cohort has several strengths. It is the largest analysis to date of the association between BP and risk of vascular dementia ( Table I in the online-only Data  Supplement) . It is also contemporary, with many individuals prescribed with antihypertensive medication and statins. However, our use of the primary care cohort does have several limitations. First, recording of dementia in primary care records has low sensitivity. 26, 27 Second, it is possible that the coding of vascular dementia would be influenced by prior hypertension because hypertension is included in most diagnostic criteria for vascular dementia. 28, 29 Given the consequent potential circularity of associations between BP and vascular dementia, we studied the risk of all new dementia in the OXVASC TIA and stroke cohort and found strong confirmatory associations between prior BP and dementia. Third, several of our covariates had high rates of missingness, including 31% for BMI and 73% for total cholesterol. However, simulation studies have suggested that multiple imputation can produce accurate estimates even at high rates of missingness, [30] [31] [32] and estimates were similar with and without adjustment for cholesterol.
In conclusion, BP is continuously related to risk of vascular dementia at baseline age of ≤70 years, and prior BP is a strong risk factor for dementia during follow-up after TIA and stroke. Although the strength of these associations declines with increasing age, previous reports of an inverse association between BP and risk of dementia in the ages 71 to 90 years were refuted. Assuming causality, individual and populationbased efforts to reduce BP and reduce the complications of cerebrovascular disease may further reduce the incidence of vascular dementia.
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Supplementary Material
Supplementary Methods Regression Dilution Bias
Measurement error and within-individual variation in a risk factor can reduce the magnitude of estimated associations between a given risk factor and future events. In order to correct for this "regression dilution bias", regression dilution ratios were calculated by regressing serial measurements of blood pressure within the median follow-up on baseline values using generalized estimate equations. Calculated hazard ratios for measured blood pressure were then multiplied by the inverse of these ratios (attenuation factor), to estimate the association for usual blood pressure. Attenuation factors of 2.17 and 2.57 were calculated for systolic and diastolic blood pressures respectively. To graph floating absolute risks against usual blood pressure, measured blood pressure was "shrunk" towards the overall mean blood pressure by the calculated regression dilution ratios.
Mediating effects of TIA and stroke
To investigate to what extent the potential association between blood pressure and vascular dementia was mediated by stroke or TIA, we adjusted for occurrence of stroke or TIA during follow up (that is, either before censoring for individuals who were not diagnosed with vascular dementia or before diagnosis of vascular dementia for individuals who were diagnosed with vascular dementia during follow-up). A stroke or TIA event was defined from either diagnosis within primary care (defined through 15 Read codes 1 ), diagnosis through cause-specific hospitalization or diagnosis through cause-specific mortality (defined through the ICD 10 codes: I60, I61, I63, I64, G46.3-G46.7, I67.2, I67.9 for stroke, and G45.8, G45.9 for TIA). To determine what proportion of the association between usual blood pressure and risk of vascular dementia was mediated by future stroke and transient ischemic attack, we calculated the percentage of excess risk mediated (PERM) using the formula: PERM = (HR(confounder adjusted) -HR(confounder adjusted and mediator adjusted))/(1-HR(confounder adjusted)). For the analysis of the mediation of the risk of vascular dementia by stroke or TIA, only the first stroke or TIA was counted (that is, we did not adjust for multiple strokes or TIAs, but adjusted for whether an individual had a stroke or TIA during follow up).
Oxford Vascular Study Methods
Patients with TIA or stroke were prospectively recruited from 1 st April 2002-31 st March 2007 into the Oxford Vascular Study (OXVASC), a prospective population-based cohort study of all acute vascular events occurring within a defined population of 92 728 covered by nine primary care practices in Oxfordshire, UK. 2, 3 The study was approved by the local research ethics committee. Informed written consent (or assent from relatives) was obtained for study interview, for face-to-face and telephone followup and for indirect follow-up using primary care physician records, hospital records and death certificate data. Where patients died before first assessment or where assent from a family member could not be obtained in patients lacking capacity, the ethics committee approved review of the patient's medical records.
The study methods have been described in detail elsewhere. [2] [3] [4] [5] Patients were ascertained after index TIA or stroke by study clinicians through a combination of hot and cold pursuit. [2] [3] [4] TIA and stroke were defined clinically by WHO criteria. 6 Baseline brain and vascular imaging was performed and all cases were reviewed by a senior vascular neurologist (PMR). Patient data were collected at study entry by interview using a standardised form and cross-referenced with primary care records. [2] [3] [4] Functional status was assessed using modified Rankin 7 and Barthel 8 scores.
The lifetime medical record held by the primary care physician was manually reviewed and all recorded premorbid BPs ascertained. All BP readings recorded in primary care records from 1990 onwards were used for determination of premorbid BP, with sensitivity analyses using readings during the last 5 years or from 5-10 years before the event.
Cognitive screening and diagnosis of dementia
Follow-up interviews were done by trained clinical research fellows or nurses at 1 and 6 months and 1 and 5 years either in a hospital clinic or by home visit where hospital visit was not possible. Telephone follow-up was done when face-to-face follow-up was not possible.
Cognitive testing was done at all follow-ups using a combination of MMSE, 9 TICSm 10 and MoCA, 11 all of which we have validated against the National Institute of Neurological Disorders and Stroke-Canadian Stroke Network (NINDS-CSN) Vascular Cognitive Impairment Harmonisation Standards Neuropsychological Battery in the OXVASC population. [11] [12] [13] [14] Since we and others have shown that exclusion of patients unavailable for clinic follow-up substantially reduces the measured rate of postevent dementia, [15] [16] [17] [18] telephone testing using the TICSm or telephone MoCA (out of 12) 14 was used in patients who were not available for face-to-face assessment (e.g. moved away from study area).
Dementia was defined as pre-or post-event according to whether the diagnosis was made before or after the index event 5 Post-event dementia diagnosis required MMSE<24 19 and remaining <24 for all subsequent follow-ups or MoCA<20 20 or TICSm<22 or Telephone-MoCA<9. 14 For subjects with an incomplete test (eg dysphasia, visual impairment, inability to use the dominant arm) individual patient study records and primary care information were reviewed. For patients without a direct face-to-face study assessment, post-event dementia was diagnosed by specialist review of all primary and secondary care medical record. 18 Supp. 30 We updated this review, using a modified version of the search strategy in this review, with the substitution of the key word "vascular dementia" for "dementia", and searching MEDLINE from January 1 st , 2005 to 29 th of April, 2015. We included all prospective studies of the association between blood pressure and vascular dementia, excluding cross-sectional studies and studies which examined the association between blood pressure and unspecified dementia. Supp . Table IV . Risk of dementia during follow-up (excluding premorbid and baseline dementia) in relation to mean pre-morbid blood pressure (hazard ratio per 20/10mmHg increase in mean SBP/DBP) readings in cohort of patients with a first TIA or stroke (OXVASC cohort) stratified by median age (approx. 75 years) and by measurement period (years prior to TIA/stroke) stratified by age, with two sensitivity analyses: 1. excluding patients on BP-lowering medication prior to the first TIA/stroke; 2. excluding dementia with onset after recurrent stroke. 
All patients
